During the past decade, Peking University First Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University First Hospital" #1 collaborator was "Affiliated Hospital of North Sichuan Medical College" with 2 trials as a collaborator, "Anshan Central Hospital" with 2 trials as a collaborator, "Baotou Central Hospital" with 2 trials as a collaborator, "Beijing Chao Yang Hospital" with 2 trials as a collaborator and "Beijing Geriatric Hospital" with 2 trials as a collaborator. Other collaborators include 119 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Peking University First Hospital" are "Familial Alzheimer Disease (FAD)" (2 trials), "Alzheimer Disease" (1 trials), "Alzheimer Disease, Late Onset" (1 trials), "Mild Cognitive Impairment(MCI)" (1 trials) and "Non-Alzheimer Degenerative Dementia" (1 trials). Many other conditions were trialed in "Peking University First Hospital" in a lesser frequency.

The vast majority of trials in "Peking University First Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Peking University First Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Peking University First Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peking University First Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".